single-center report on 10 patients Hematopoietic stem cell transplantation in Griscelli syndrome type 2: a

[1]  L. Notarangelo,et al.  Primary immunodeficiency diseases , 2013 .

[2]  A. Fischer,et al.  Neutralization of IFNγ defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice , 2009, EMBO molecular medicine.

[3]  H. Hasle,et al.  Treatment of the X‐linked lymphoproliferative, Griscelli and Chédiak–Higashi syndromes by HLH directed therapy , 2009, Pediatric blood & cancer.

[4]  E. Lanino,et al.  Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP) , 2008, Haematologica.

[5]  A. Fischer,et al.  A Griscelli syndrome type 2 murine model of hemophagocytic lymphohistiocytosis (HLH) , 2008, European journal of immunology.

[6]  M. Nordenskjöld,et al.  Characterization of PRF1, STX11 and UNC13D genotype‐phenotype correlations in familial hemophagocytic lymphohistiocytosis , 2008, British journal of haematology.

[7]  A. Filipovich,et al.  Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step , 2008, Bone Marrow Transplantation.

[8]  O. De Wever,et al.  A novel missense mutation (G43S) in the switch I region of Rab27A causing Griscelli syndrome. , 2008, Molecular genetics and metabolism.

[9]  M. Yeganeh,et al.  Analysis of RAB27A Gene in Griscelli Syndrome type 2: Novel Mutations Including a Deletion Hotspot , 2008, Journal of Clinical Immunology.

[10]  H. Gadner,et al.  Frequency and spectrum of central nervous system involvement in 193 children with haemophagocytic lymphohistiocytosis , 2008, British journal of haematology.

[11]  J. Casanova,et al.  IFN-γ Mediates the Rejection of Haematopoietic Stem Cells in IFN-γR1-Deficient Hosts , 2008, PLoS medicine.

[12]  A. Fischer,et al.  Immunotherapy of Familial Hemophagocytic Lymphohistiocytosis With Antithymocyte Globulins: A Single-Center Retrospective Report of 38 Patients , 2007, Pediatrics.

[13]  A. Fischer,et al.  Genetic defects affecting lymphocyte cytotoxicity. , 2007, Current opinion in immunology.

[14]  H. Achdout,et al.  NK cytotoxicity mediated by CD16 but not by NKp30 is functional in Griscelli syndrome. , 2007, Blood.

[15]  B. Beutler,et al.  Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis , 2007, The Journal of Experimental Medicine.

[16]  M. Aricò,et al.  HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.

[17]  A. Aghamohammadi,et al.  Bilateral basal ganglia involvement in a patient with Griscelli syndrome. , 2006, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[18]  U. Heinzmann,et al.  A missense mutation in the WD40 domain of murine Lyst is linked to severe progressive Purkinje cell degeneration , 2006, Acta Neuropathologica.

[19]  A. Fischer,et al.  Hematopoietic Stem Cell Transplantation in Hemophagocytic Lymphohistiocytosis: A Single-Center Report of 48 Patients , 2006, Pediatrics.

[20]  P. Veys,et al.  Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis. , 2006, Blood.

[21]  D. Aslan,et al.  GRISCELLI SYNDROME: Description of a Case with Rab27A Mutation , 2006, Pediatric hematology and oncology.

[22]  A. Fischer,et al.  Progressive neurologic dysfunctions 20 years after allogeneic bone marrow transplantation for Chediak-Higashi syndrome. , 2005, Blood.

[23]  A. Fischer,et al.  Primary hemophagocytic syndromes point to a direct link between lymphocyte cytotoxicity and homeostasis , 2005, Immunological reviews.

[24]  L. Silverman,et al.  Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. , 2004, Blood.

[25]  A. Fischer,et al.  Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1). , 2003, The Journal of clinical investigation.

[26]  O. Sanal,et al.  Griscelli Disease: Genotype–Phenotype Correlation in an Array of Clinical Heterogeneity , 2002, Journal of Clinical Immunology.

[27]  F. Locatelli,et al.  Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation , 2002, Bone Marrow Transplantation.

[28]  A. Fischer,et al.  Functional consequences of perforin gene mutations in 22 patients with familial haemophagocytic lymphohistiocytosis , 2002, British journal of haematology.

[29]  I. Schmid,et al.  Griscelli syndrome: report of the first peripheral blood stem cell transplant and the role of mutations in the RAB27A gene as an indication for BMT , 2001, Bone Marrow Transplantation.

[30]  A. Plebani,et al.  Interleukin-2 mediated restoration of natural killer cell function in a patient with Griscelli syndrome , 2000, European Journal of Pediatrics.

[31]  G. de Saint Basile,et al.  Perforin: more than just an effector molecule. , 2000, Immunology today.

[32]  A. Fischer,et al.  Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome , 2000, Nature Genetics.

[33]  I. Tezcan,et al.  Successful bone marrow transplantation in a case of Griscelli disease which presented in accelerated phase with neurological involvement , 1999, Bone Marrow Transplantation.

[34]  C. Durán-McKinster,et al.  Elejalde syndrome--a melanolysosomal neurocutaneous syndrome: clinical and morphological findings in 7 patients. , 1999, Archives of dermatology.

[35]  A. Fischer,et al.  Griscelli disease maps to chromosome 15q21 and is associated with mutations in the Myosin-Va gene , 1997, Nature Genetics.

[36]  M. Steinbuch,et al.  Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. , 1997, Blood.

[37]  W. Gahl,et al.  Molecular cloning and characterization of rab27a and rab27b, novel human rab proteins shared by melanocytes and platelets. , 1997, Biochemical and molecular medicine.

[38]  E D Thomas,et al.  1994 Consensus Conference on Acute GVHD Grading. , 1995, Bone marrow transplantation.

[39]  C. Klein,et al.  Partial albinism with immunodeficiency (Griscelli syndrome). , 1994, The Journal of pediatrics.

[40]  F. Ledeist,et al.  Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. , 1993, Blood.

[41]  R. Geha,et al.  Bone marrow transplantation (BMT) for the syndrome of pigmentary dilution and lymphohistiocytosis (Griscelli's syndrome) , 1990, Journal of Clinical Immunology.

[42]  L. Grochow,et al.  VENOOCCLUSIVE DISEASE OF THE LIVER FOLLOWING BONE MARROW TRANSPLANTATION , 1987, Transplantation.

[43]  C. Griscelli,et al.  A syndrome associating partial albinism and immunodeficiency. , 1978, The American journal of medicine.

[44]  C. Chang,et al.  Central nervous system graft-versus-host disease: report of two cases and literature review , 2007, Bone Marrow Transplantation.